Hospital-based seroepidemiological analysis of varicella antibodies in children without history of varicella disease
The Journal of Infection in Developing Countries · 2025
DOI: 10.3855/jidc.20424 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Zhongyang Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Health Statistics, School of Public Health, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Antibodies, Viral, Chickenpox, Herpesvirus 3, Human. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
There are no published studies on the anti-varicella zoster virus (VZV) IgG antibody status of children in Qingdao. Thus, the aim of the present study was to investigate anti-VZV antibody status in hospital-based children aged 0–13 years without a history of varicella disease. Methodology: Children aged 0–13 years in Qingdao were included in the study population. The demographic data and vaccination histories of all the subjects were obtained from the Shandong Information System for Immunization Program. Varicella disease history data was obtained from the Chinese Information System for Disease Control and Prevention. Enzyme-linked immunosorbent assay was used for detecting anti-VZV IgG in serum samples, and the seropositivity rate and geometric mean concentration (GMC) of the antibody were analyzed.
Results
A total of 983 children were included in the study. The seropositivity rate was 55.04%, and the GMC was 121.74 mIU/mL. The seropositivity rate and antibody GMC were significantly higher in females than in males (p < 0.05) and significantly higher in children aged 4–6 years than in children aged < 4 years and 7–13 years (p < 0.001). The seropositivity rate and GMC in children increased with vaccine dose (p < 0.001). In contrast to the considerable decline in antibody levels 3–5 years after one dose of varicella vaccination, antibody levels observed at least 8 years after two doses of varicella vaccination showed no considerable decline.
Conclusions
Two-dose varicella vaccination is recommended for inclusion in China’s national immunization program.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Health Statistics, School of Public Health, Qingdao University, Qingdao, China.
- Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- Qingdao Municipal Center for Disease Control and Prevention, Qingdao Institute of Preventive Medicine, Qingdao, China.
Zitieren
APA
Zhang, Z., Chen, Z., Li, X., Hu, P., Hao, S., Liu, S., & Yang, F. (2025). Hospital-based seroepidemiological analysis of varicella antibodies in children without history of varicella disease. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.20424
Vancouver
Zhang Z, Chen Z, Li X, Hu P, Hao S, Liu S, et al. Hospital-based seroepidemiological analysis of varicella antibodies in children without history of varicella disease. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.20424
BibTeX
@article{Zhang2025,
author = {Zhang, Zhongyang and Chen, Zengsheng and Li, Xiaofan and Hu, Ping and Hao, Sicheng and Liu, Sitong and Yang, Feng},
title = {Hospital-based seroepidemiological analysis of varicella antibodies in children without history of varicella disease},
journal = {The Journal of Infection in Developing Countries},
year = {2025},
doi = {10.3855/jidc.20424}
}
EUVIMED